Inflammatory markers (e.g., acute phase proteins and especially C-reactive protein (CRP), leukocytosis, thrombocytosis) are associated with prognosis in several malignancies, including head and neck cancer/squamous cell carcinoma (HNSCC) [8,9,10]. This evidence concerns the gene CRP and Increased total leukocyte count.